|
1
|
Wei WI and Sham JS: Nasopharyngeal
carcinoma. Lancet. 365:2041–2054. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Razak AR, Siu LL, Liu FF, Ito E,
O‘Sullivan B and Chan K: Nasopharyngeal carcinoma: the next
challenges. Eur J Cancer. 46:1967–1978. 2010. View Article : Google Scholar
|
|
3
|
Xiao WW, Huang SM, Han F, Wu SX, Lu LX,
Lin CG, Deng XW, Lu TX, Cui NJ and Zhao C: Local control, survival,
and late toxicities of locally advanced nasopharyngeal carcinoma
treated by simultaneous modulated accelerated radiotherapy combined
with cisplatin concurrent chemotherapy: long-term results of a
phase 2 study. Cancer. 117:1874–1883. 2011. View Article : Google Scholar
|
|
4
|
Chan AT, Hsu MM, Goh BC, Hui EP, Liu TW,
Millward MJ, Hong RL, Whang-Peng J, Ma BB, To KF, Mueser M, Amellal
N, Lin X and Chang AY: Multicenter, phase II study of cetuximab in
combination with carboplatin in patients with recurrent or
metastatic nasopharyngeal carcinoma. J Clin Oncol. 23:3568–3576.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee AW, Tung SY, Chan AT, Chappell R, Fu
YT, Lu TX, Tan T, Chua DT, O‘sullivan B, Xu SL, Pang ES, Sze WM,
Leung TW, Kwan WH, Chan PT, Liu XF, Tan EH, Sham JS, Siu L and Lau
WH: Preliminary results of a randomized study (NPC-9902 Trial) on
therapeutic gain by concurrent chemotherapy and/or accelerated
fractionation for locally advanced nasopharyngeal carcinoma. Int J
Radiat Oncol Biol Phys. 66:142–151. 2006. View Article : Google Scholar
|
|
6
|
Cao Y, Popovtzer A, Li D, Chepeha DB,
Moyer JS, Prince ME, Worden F, Teknos T, Bradford C, Mukherji SK
and Eisbruch A: Early prediction of outcome in advanced
head-and-neck cancer based on tumor blood volume alterations during
therapy: a prospective study. Int J Radiat Oncol Biol Phys.
72:1287–1290. 2008.PubMed/NCBI
|
|
7
|
Korpanty G, Carbon JG, Grayburn PA,
Fleming JB and Brekken RA: Monitoring response to anticancer
therapy by targeting microbubbles to tumor vasculature. Clin Cancer
Res. 13:323–330. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen JJ, Fu SY, Chiang CS, Hong JH and Yeh
CK: A preclinical study to explore vasculature differences between
primary and recurrent tumors using ultrasound Doppler imaging.
Ultrasound Med Biol. 39:860–869. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yankeelov TE, Niermann KJ, Huamani J, Kim
DW, Quarles CC, Fleischer AC, Hallahan DE, Price RR and Gore JC:
Correlation between estimates of tumor perfusion from microbubble
contrast-enhanced sonography and dynamic contrast-enhanced magnetic
resonance imaging. J Ultrasound Med. 25:487–497. 2006.
|
|
10
|
Beaton C, Cochlin D and Kumar N: Contrast
enhanced ultrasound should be the initial radiological
investigation to characterise focal liver lesions. Eur J Surg
Oncol. 36:43–46. 2010. View Article : Google Scholar
|
|
11
|
Ridolfi F, Abbattista T, Busilacchi P and
Brunelli E: Contrast-enhanced ultrasound evaluation of hepatic
microvascular changes in liver diseases. World J Gastroenterol.
18:5225–5230. 2012.PubMed/NCBI
|
|
12
|
Rissanen TT, Korpisalo P, Karvinen H,
Liimatainen T, Laidinen S, Gröhn OH and Ylä-Herttuala S:
High-resolution ultrasound perfusion imaging of therapeutic
angiogenesis. JACC Cardiovasc Imaging. 1:83–91. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Badea AF, Tamas-Szora A, Clichici S,
Socaciu M, Tăbăran AF, Băciut G, Cătoi C, Mureşan A, Buruian M and
Badea R: Contrast enhanced ultrasonography (CEUS) in the
characterization of tumor microcirculation. Validation of the
procedure in the animal experimental model. Med Ultrason. 15:85–94.
2013. View Article : Google Scholar
|
|
14
|
Shah JP, Ang K, Baatenburg De Jong RJ, et
al: Head and neck. AJCC Cancer Staging Manual. Edge SB, Byrd DR,
Compton CC, Fritz AG, Greene FL and Trotti A: 7th edition.
Springer; New York: pp. 21–100. 2010
|
|
15
|
Ramakrishnan MS, Eswaraiah A, Crombet T,
Piedra P, Saurez G, Iyer H and Arvind AS: Nimotuzumab, a promising
therapeutic monoclonal for treatment of tumors of epithelial
origin. MAbs. 1:41–48. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ang J, Hu L, Huang PT, Wu JX, Huang LN,
Cao CH, Zheng YX and Chen L: Contrast-enhanced ultrasonography
assessment of gastric cancer response to neoadjuvant chemotherapy.
World J Gastroenterol. 18:7026–7032. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Moschouris H, Malagari K, Marinis A,
Kornezos I, Stamatiou K, Nikas G, Papadaki MG and Gkoutzios P:
Hepatocellular carcinoma treated with transarterial
chemoembolization: Evaluation with parametric contrast-enhanced
ultrasonography. World J Radiol. 4:379–386. 2012. View Article : Google Scholar
|
|
18
|
Chawla S, Kim S, Dougherty L, Wang S,
Loevner LA, Quon H and Poptani H: Pretreatment diffusion-weighted
and dynamic contrast-enhanced MRI for prediction of local treatment
response in squamous cell carcinomas of the head and neck. AJR Am J
Roentgenol. 200:35–43. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Eisenhauer EA, Therasse P, Bogaerts J,
Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S,
Mooney M, Rubinstein L, Shankar L, Dodd L, Kaplan R, Lacombe D and
Verweij J: New response evaluation criteria in solid tumours:
revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247.
2009. View Article : Google Scholar
|
|
20
|
Shukla-Dave A, Lee NY, Jansen JF, Thaler
HT, Stambuk HE, Fury MG, Patel SG, Moreira AL, Sherman E, Karimi S,
Wang Y, Kraus D, Shah JP, Pfister DG and Koutcher JA: Dynamic
contrast-enhanced magnetic resonance imaging as a predictor of
outcome in head-and-neck squamous cell carcinoma patients with
nodal metastases. Int J Radiat Oncol Biol Phys. 82:1837–1844. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim S, Loevner LA, Quon H, Kilger A,
Sherman E, Weinstein G, Chalian A and Poptani H: Prediction of
response to chemoradiation therapy in squamous cell carcinomas of
the head and neck using dynamic contrast-enhanced MR imaging. AJNR
Am J Neuroradiol. 31:262–268. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Knieling F, Waldner MJ, Goertz RS, Zopf S,
Wildner D, Neurath MF, Bernatik T and Strobel D: Early response to
anti-tumoral treatment in hepatocellular carcinoma - can
quantitative contrast-enhanced ultrasound predict outcome?
Ultraschall Med. 34:38–46. 2013.PubMed/NCBI
|
|
23
|
Schirin-Sokhan R, Winograd R, Roderburg C,
Bubenzer J, do Ó NC, Guggenberger D, Hecker H, Trautwein C and
Tischendorf JJ: Response evaluation of chemotherapy in metastatic
colorectal cancer by contrast enhanced ultrasound. World J
Gastroenterol. 18:541–545. 2012. View Article : Google Scholar : PubMed/NCBI
|
